Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9V74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,471
Award facts
- Contract value 100% obligated
- $58,470.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $58,470.54 for Renflexis 100 mg vials by the Defense Logistics Agency. This firm fixed-price delivery order, issued on January 8, 2026, with completion scheduled for January 9, 2026, represents a non-competitive child order under AmerSourceBergen's parent company Cencora, Inc.'s broader pharmaceutical supply relationship with the federal government. Renflexis is an infliximab biosimilar used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis, and this delivery supports the military healthcare supply chain.
This delivery order falls under Cencora's significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The overarching IDC serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military treatment facilities and veteran healthcare programs globally. AmerSourceBergen's role as the prime contractor reflects its established capability and competitive position as a critical pharmaceutical vendor within the federal medical supply chain, particularly for the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9V74?
SPE2DR26F9V74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9V74 worth?
The government has obligated $58,471 on SPE2DR26F9V74.
Is contract SPE2DR26F9V74 an order under another contract?
Yes. SPE2DR26F9V74 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V74 competed?
The extent of competition for SPE2DR26F9V74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award